These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 26363038)
1. Synthetic Cannabinoid Receptor Agonists: a heterogeneous class of novel psychoactive substance with emerging risk of psychosis. Whiting D Evid Based Ment Health; 2015 Nov; 18(4):110. PubMed ID: 26363038 [No Abstract] [Full Text] [Related]
2. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. van Amsterdam J; Brunt T; van den Brink W J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398 [TBL] [Abstract][Full Text] [Related]
3. Human Laboratory Studies on Cannabinoids and Psychosis. Sherif M; Radhakrishnan R; D'Souza DC; Ranganathan M Biol Psychiatry; 2016 Apr; 79(7):526-38. PubMed ID: 26970363 [TBL] [Abstract][Full Text] [Related]
4. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids. Hopkins CY; Gilchrist BL J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687 [TBL] [Abstract][Full Text] [Related]
5. Cannabis and psychosis: what do we know and what should we do? Colizzi M; Murray R Br J Psychiatry; 2018 Apr; 212(4):195-196. PubMed ID: 29557759 [TBL] [Abstract][Full Text] [Related]
11. Psychosis and synthetic cannabinoids. Deng H; Verrico CD; Kosten TR; Nielsen DA Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871 [TBL] [Abstract][Full Text] [Related]
12. [Cannabis and cannabinoids as drugs]. Khiabani HZ; Mørland J Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810 [TBL] [Abstract][Full Text] [Related]
13. Psychotic Disorders in Patients Who Use Synthetic Cannabinoids. Skryabin VY; Vinnikova MA J Psychiatr Pract; 2019 Nov; 25(6):485-490. PubMed ID: 31821228 [TBL] [Abstract][Full Text] [Related]
14. Psychosis-Relevant Effects of Intravenous Delta-9-Tetrahydrocannabinol: A Mega Analysis of Individual Participant-Data from Human Laboratory Studies. Ganesh S; Cortes-Briones J; Ranganathan M; Radhakrishnan R; Skosnik PD; D'Souza DC Int J Neuropsychopharmacol; 2020 Dec; 23(9):559-570. PubMed ID: 32385508 [TBL] [Abstract][Full Text] [Related]
15. Hemorrhagic stroke following use of the synthetic marijuana "spice". Rose DZ; Guerrero WR; Mokin MV; Gooch CL; Bozeman AC; Pearson JM; Burgin WS Neurology; 2015 Sep; 85(13):1177-9. PubMed ID: 26320200 [No Abstract] [Full Text] [Related]
16. ["Spice"--synthetic cannabinoids with dangerous effects]. Personne M; Westerbergh J; Hammer-Pettersen L Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644 [TBL] [Abstract][Full Text] [Related]
17. Synthetic cannabinoid induced psychosis in a previously nonpsychotic patient. Peglow S; Buchner J; Briscoe G Am J Addict; 2012; 21(3):287-8. PubMed ID: 22494236 [No Abstract] [Full Text] [Related]
18. [Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids]. Kekelidze ZI; Klimenko TV; Kozlov AA; Shakhova SM Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):21-26. PubMed ID: 29376979 [TBL] [Abstract][Full Text] [Related]